Mentice Q1 2025 Interim Report earnings call
Register now
Mentice publishes Annual Report 2024
Read More
Mentice Secures $648,410 USD Combined Order for Advanced Simulation Solutions from a Top 20 Global MedTech company
Learn More
English / Svenska
Investor > Press Releases >
Mentice to Present Q1 2025 Interim Report via Webcast

Mentice to Present Q1 2025 Interim Report via Webcast

Wednesday, April 30, 2025

Mentice AB (STO: MNTC) announces that the company will present its Q1 2025 Interim Report for the period January–March via a webcast conference call on Thursday, May 8, 2025, at 10:00 CEST.

The webcast will feature presentations from CEO, Frans Venker and CFO, Ulrika Drotz, who will share key insights into the company’s financial results and strategic progress. The session will conclude with a live Q&A, moderated by Rikard Engberg, Analyst at Carnegie.

The presentation will be conducted in English, and participants are encouraged to register in advance.

For registration details and access to the webcast, please visit https://investor.mentice.com/.

For more information, please contact:
Stacy Hammar, Senior Marketing Manager, Mentice
E-post: stacy.hammar@mentice.com
Mobile: +46 732 345 285

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Mentice to Present Q1 2025 Interim Report via Webcast

SHARE INFORMATION
The StockTop 10 ShareholdersCertified Advisor
PRESS RELEASES
All2022202120202019
FINANCIAL CALENDAR
Financial Calendar
financial reports
All
2022
2021
2020
2019
2023
2024
2025
CORPORATE GOVERNANCE
Corporate GovernanceArticle of AssociationGeneral MeetingsBoard of DirectorsSenior ManagementAuditorsBoard CommitteesCorporate Share HoldingsGuidelines for RemunerationNomination CommitteeSustainabilityMedia
other
About usContactCompany PresentationBack to Mentice
Data PolicyQuality PolicyDisclaimerTerms
Copyright © 2023 Mentice AB (publ) . All rights reserved.
Mentice Q1 2025 delårsrapport webcast
Anmäl dig nu
Mentice publicerar årsredovisning 2024
Läs mer
Mentice får en total order på avancerade simuleringslösningar värd $648,410 USD från ett topp 20 globalt medtech bolag
Läs Mer
English / Svenska
Investor > Pressmeddelanden >
Mentice to Present Q1 2025 Interim Report via Webcast

Mentice to Present Q1 2025 Interim Report via Webcast

Wednesday, April 30, 2025

Mentice AB (STO: MNTC) announces that the company will present its Q1 2025 Interim Report for the period January–March via a webcast conference call on Thursday, May 8, 2025, at 10:00 CEST.

The webcast will feature presentations from CEO, Frans Venker and CFO, Ulrika Drotz, who will share key insights into the company’s financial results and strategic progress. The session will conclude with a live Q&A, moderated by Rikard Engberg, Analyst at Carnegie.

The presentation will be conducted in English, and participants are encouraged to register in advance.

For registration details and access to the webcast, please visit https://investor.mentice.com/.

For more information, please contact:
Stacy Hammar, Senior Marketing Manager, Mentice
E-post: stacy.hammar@mentice.com
Mobile: +46 732 345 285

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Mentice to Present Q1 2025 Interim Report via Webcast

AKTIEINFORMATION
AktieinformationTop 10 AktieägareCertifierad RådgivareIncitamentsprogram för anställda
PRESSMEDDELANDEN
Alla2022202120202019
FINASIELL KALENDER
Finansiell kalender
FINANSIELLA RAPPORTER
Alla
2022
2021
2020
2019
2023
2024
2025
BOLAGSSTYRNING
BolagsstyrningBolagsordningBolagsstämmorStyrelseKoncernledningRevisorerStyrelseutskottStyrelsens AktieägandeRiktlinjer för ersättningValberedningHållbarhetMedia
ANNAT
KontaktFöretags PresentationTillbaka till Mentice
Data PolicyQuality PolicyDisclaimerTerms
Copyright © 2022 Mentice AB (publ) . All rights reserved.